
Arialys Therapeutics Publishes Preclinical Data in Nature Communications Supporting ART5803 as a First-in-Class Precision Therapeutic for Anti-NMDA Receptor Autoimmune Neuropsychiatric Disease
'This study underscores the promise of ART5803 to directly address neuropsychiatric disease caused by anti-NMDA receptor-targeting pathogenic antibodies,' said Peter Flynn, Ph.D. President and CEO of Arialys Therapeutics.
Share
'This study underscores the promise of ART5803 to directly address neuropsychiatric disease caused by anti-NMDA receptor-targeting pathogenic antibodies,' said Peter Flynn, Ph.D. President and CEO of Arialys Therapeutics. 'Despite our understanding of the disease mechanism and its severity, ANRE lacks an approved therapy. Further, there is a growing body of data identifying significant levels of anti-NMDA receptor autoantibodies in subpopulations of patients diagnosed with diseases that result in psychosis and dementia.'
'These data provide compelling evidence that ART5803 can directly block the pathogenic effect of autoantibodies that target the NMDA receptor, resulting in a rapid resolution of symptoms,' said Mitsuyuki (Mickey) Matsumoto, Ph.D., Chief Scientific Officer of Arialys Therapeutics and senior author of the paper. 'Our detailed structural and functional analyses confirm that ART5803 precisely inhibits NMDA receptor internalization induced by the pathogenic autoantibodies, while preserving normal receptor function. In addition, our discovery of a potential molecular mimicry mechanism for anti-NMDA receptor autoantibody generation broadens the understanding of disease initiation and may inform future indication expansion for ART5803.'
Anti-NMDA receptor encephalitis (ANRE) is a rare, potentially lethal, poorly managed, and often misdiagnosed neurological disease. ANRE is caused by pathogenic autoantibodies that bind to and crosslink NMDA receptors in the brain, leading to receptor internalization and synaptic dysfunction. The result is a range of debilitating neuropsychiatric symptoms including psychiatric and behavioral alterations, cognitive decline, seizures, coma, and diminished autonomic function. A significant percentage of ANRE patients are pediatric, where NMDA receptor-specific autoantibodies can also result in neurological development deficits. There are no approved therapies for this disease, and current treatments rely on broadly immunosuppressive therapies, which are associated with delayed efficacy and significant side effects.
Recent findings have also identified anti-NMDA receptor autoantibodies in other neurological and psychiatric diseases such as schizophrenia, depression, bipolar disorder, and dementia. Arialys is planning clinical assessment of ART5803 in anti-NMDA receptor autoantibody-positive psychosis patients. The company is also currently testing patient samples using a proprietary high-throughput screen for autoantibodies to identify enriched disease indications and subpopulations for future clinical development.
ART5803 is a humanized, monovalent IgG1 antibody engineered to selectively bind the GluN1 subunit of the NMDA receptor without disrupting receptor function or causing internalization. In this study, ART5803 demonstrated the ability to potently block NMDA receptor internalization in cellular and neuronal models and reversed both molecular and behavioral hallmarks of disease in a novel marmoset model of ANRE. Notably, ART5803 exhibited rapid onset of action and was well tolerated in vivo. The publication also includes a detailed characterization of ART5803's binding epitope, its mechanism of action, and population pharmacokinetic modeling supporting the feasibility of systemic administration in patients.
In addition to demonstrating the therapeutic potential of ART5803, the paper revealed a potential link between infections—specifically Toxoplasma gondii and certain bacterial pathogens—and the generation of pathogenic anti-NMDA receptor autoantibodies. Epitope mapping analysis identified regions of potential molecular mimicry between microbial proteins and the GluN1 subunit of the NMDA receptor, suggesting that infections could serve as environmental triggers for disease initiation. Notably, toxoplasmosis and bacterial infections are well-established risk factors for a range of neuropsychiatric conditions. These findings not only suggest a basis for disease pathogenesis but also support broader therapeutic opportunities for ART5803 across autoimmune neuropsychiatric disorders.
ART5803 is currently being evaluated in a Phase 1 clinical trial in healthy volunteers. In February 2025, Arialys announced completion of all single ascending dose (SAD) cohorts and initiation of multiple ascending dose (MAD) cohorts. The company expects to share initial clinical data in the second half of 2025 and initiate Phase 2 proof-of-concept studies.
The publication was completed in collaboration with researchers from Astellas Pharma Inc., University of California, Davis, Kitasato University School of Medicine, and Vanadro LLC.
About Arialys Therapeutics
Arialys was founded by investors Avalon Bioventures, Catalys Pacific and MPM to meaningfully expand the treatment possibilities for neuropsychiatric disorders driven by autoimmune disease. Using a combination of highly sensitive autoantibody detection, patient sampling and receptor structural biology, Arialys has developed a first-in-class precision therapy to specifically block pathogenic autoantibodies in the brain. Arialys is headquartered in La Jolla, California. For more information, visit www.arialysrx.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Renesas Announces Consolidated Forecasts
TOKYO, July 25, 2025--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE: 6723), a premier supplier of advanced semiconductor solutions, today announced the consolidated financial forecasts for the nine months ending September 30, 2025. Renesas Electronics Group ("the Group") reports its consolidated forecasts on a quarterly basis as a range because of the difficulty of forecasting full-year results with high accuracy due to the short-term volatility of the semiconductor market. Additionally, in order to provide useful information to better understand the Group's constant business results, figures such as revenue, gross margin, and operating margin are presented in the non-GAAP format, which excludes or adjusts the non-recurring items related to acquisitions and other adjustments, including non-recurring expenses or income from the financial figures (GAAP, IFRS basis) following a certain set of rules. The gross margin and operating margin forecasts are given assuming the midpoint in the revenue forecast. Consolidated forecasts for the nine months ending September 30, 2025(January 1, 2025 to September 30, 2025) In millions of yen Non-GAAPRevenue Non-GAAP Gross Margin Non-GAAP Operating Margin Previous forecasts --- --- --- Forecasts as ofJuly 25, 2025 955,914to 970,914 56.7% 27.5% Increase (decrease) --- --- --- Percentage change --- --- --- Reference: Corresponding period of the previous year (January 1, 2024 to September 30, 2024) 1,055,879 56.4% 30.5% Note: Non-GAAP figures are calculated by removing or adjusting non-recurring items and other adjustments from GAAP (IFRS basis) figures following a certain set of rules. The Group believes non-GAAP measures provide useful information in understanding and evaluating the Group's constant business results, and, therefore, forecasts are provided on a non-GAAP basis. This adjustment and exclusion include the amortization of intangible assets recognized from acquisitions, other PPA (purchase price allocation) adjustments and stock-based compensation, as well as other non-recurring expenses and income the Group believes to be applicable. The consolidated forecasts for the nine months ending September 30, 2025, are calculated by combining the forecasts for the three months ending September 30, 2025, with the financial results of the six months ended June 30, 2025. The consolidated forecasts for the nine months ending September 30, 2025, are calculated at the rate of 148 yen per USD and 164 yen per Euro. Refer to Renesas' earnings report "Renesas Reports Financial Results for the Second Quarter Ended June 30, 2025", issued on July 25, 2025, for more details. The statements with respect to the financial outlook of the Group are forward-looking statements involving risks and uncertainties. The Group cautions that actual results may vary materially from such forward-looking statements due to several important factors listed in the "Forward-Looking Statements" below. About Renesas Electronics Corporation Renesas Electronics Corporation (TSE: 6723) empowers a safer, smarter and more sustainable future where technology helps make our lives easier. A leading global provider of microcontrollers, Renesas combines our expertise in embedded processing, analog, power and connectivity to deliver complete semiconductor solutions. These Winning Combinations accelerate time to market for automotive, industrial, infrastructure and IoT applications, enabling billions of connected, intelligent devices that enhance the way people work and live. Learn more at Follow us on LinkedIn, Facebook, Twitter, YouTube, and Instagram. (FORWARD-LOOKING STATEMENTS) The statements in this press release with respect to the plans, strategies and financial outlook of Renesas and its consolidated subsidiaries (collectively "we") are forward-looking statements involving risks and uncertainties. Such forward-looking statements do not represent any guarantee by management of future performance. In many cases, but not all, we use such words as "aim," "anticipate," "believe," "continue," "endeavor," "estimate," "expect," "initiative," "intend," "may," "plan," "potential," "probability," "project," "risk," "seek," "should," "strive," "target," "will" and similar expressions to identify forward-looking statements. You can also identify forward-looking statements by discussions of strategy, plans or intentions. These statements discuss future expectations, identify strategies, contain projections of our results of operations or financial condition, or state other forward-looking information based on our current expectations, assumptions, estimates and projections about our business and industry, our future business strategies and the environment in which we will operate in the future. Known and unknown risks, uncertainties and other factors could cause our actual results, performance or achievements to differ materially from those contained or implied in any forward-looking statement, including, but not limited to, general economic conditions in our markets, which are primarily Japan, North America, Asia, and Europe; demand for, and competitive pricing pressure on, products and services in the marketplace; ability to continue to win acceptance of products and services in these highly competitive markets; and fluctuations in currency exchange rates, particularly between the yen and the U.S. dollar. Among other factors, downturn of the world economy; deteriorating financial conditions in world markets, or deterioration in domestic and overseas stock markets, may cause actual results to differ from the projected results forecast. This press release is based on the economic, regulatory, market and other conditions as in effect on the date hereof. It should be understood that subsequent developments may affect the information contained in this presentation, which neither we nor our advisors or representatives are under an obligation to update, revise or affirm. View source version on Contacts Media Contact:Corporate Communications Office+81 3-6773-3001pr@ Investor Relations Contact: Investor Relations+81 3-6773-3002ir@


Business Wire
25 minutes ago
- Business Wire
Renesas Reports Financial Results for the Second Quarter Ended June 30, 2025
TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results in accordance with IFRS for the three and six months ended June 30, 2025. Summary of Consolidated Financial Results (Note 1) Summary of Consolidated Financial Results (Non-GAAP basis) (Note 2) Three months ended June 30, 2025 Six months ended June 30, 2025 Billion yen % of Revenue Billion yen % of Revenue Revenue 324.6 100.0 633.4 100.0 Gross profit 184.4 56.8 359.6 56.8 Operating profit 91.9 28.3 175.7 27.7 Profit attributable to owners of parent 77.8 24.0 151.1 23.9 EBITDA (Note 3) 110.2 33.9 213.7 33.7 Expand Summary of Consolidated Financial Results (IFRS basis) Reconciliation of Non-GAAP gross profit to IFRS gross profit and Non-GAAP operating profit to IFRS operating profit (Billion yen) (Note) 1. All figures are rounded to the nearest 100 million yen. 2. Non-GAAP figures are calculated by removing or adjusting non-recurring items and other adjustments from GAAP (IFRS) figures following a certain set of rules. The Group believes non-GAAP measures provide useful information in understanding and evaluating the Group's constant business results. 3. Operating profit + Depreciation and amortization. 4. Non-recurring revenue that the Group has determined should be excluded 5. 'Other reconciliation items in non-recurring expenses and adjustments' includes the non-recurring items related to acquisitions and other adjustments as well as non-recurring profits or losses the Group believes to be applicable. Expand Consolidated Financial Results for the Second Quarter Ended June 30, 2025 English translation from the original Japanese-language document July 25, 2025 (Amounts are rounded to the nearest million yen) 1. Consolidated financial results for the six months ended June 30, 2025 1.1 Consolidated financial results (% of change from corresponding period of the previous year) Revenue Operating profit Profit before tax Profit Profit attributable to owners of parent Total comprehensive income Million yen % Million yen % Million yen % Million yen % Million yen % Million yen % Six months ended June 30, 2025 634,311 (10.7) 61,301 (58.4) (169,288) - (175,321) - (175,342) - (475,677) - Six months ended June 30, 2024 710,597 (2.4) 147,508 - 165,985 - 139,743 - 139,587 - 496,716 - Expand Basic earnings per share Diluted earnings per share Yen Yen Six months ended June 30, 2025 (97.34) (97.34) Six months ended June 30, 2024 78.25 77.20 Expand (Note) 1. The Group finalized the provisional accounting treatment for the business combination at the end of December 31, 2024, and each figure for the six months ended June 30, 2024 reflects the details of the finalization of the provisional accounting treatment. 2. Diluted earnings per share is the same as basic earnings per share as there were no dilutive potential common shares outstanding for the six months ended June 30, 2025. Expand 1.2 Consolidated financial position Total assets Total equity Equity attributable to owners Ratio of equity attributable to owners Million yen Million yen Million yen % June 30, 2025 3,872,164 2,036,305 2,031,527 52.5 December 31, 2024 4,490,436 2,542,298 2,537,382 56.5 Expand 2. Cash dividends Cash dividends per share At the end of first quarter At the end of second quarter At the end of third quarter At the end of year Total Yen Yen Yen Yen Yen Year ended December 31, 2024 0.00 0.00 0.00 28.00 28.00 Year ending December 31, 2025 0.00 0.00 Year ending December 31, 2025 (forecast) --- --- --- Expand (Note) Change in forecast of cash dividends since the most recently announced forecast: No Expand 3. Forecast of consolidated results for the nine months ending September 30, 2025 (% of change from corresponding period of the previous year) (Note) 1. The Group reports its consolidated forecast on a quarterly basis (cumulative quarters) as substitute for a yearly forecast in a range format. The non-GAAP gross margin and the non-GAAP operating margin forecasts are provided assuming the midpoint in the non-GAAP revenue forecast. 2. Non-GAAP figures are calculated by removing or adjusting non-recurring items and other adjustments from GAAP (IFRS) figures following a certain set of rules. The Group believes non-GAAP measures provide useful information in understanding and evaluating the Group's constant business results, and therefore forecasts are provided on a non-GAAP basis. Expand 4. Others 4.1 Changes in significant subsidiaries for the six months ended June 30, 2025: No 4.2 Changes in Accounting Policies, Changes in Accounting Estimates and Corrections of Prior Period Errors 1. Changes in accounting policies with revision of accounting standard: No 2. Changes in accounting policies except for 4.2.1: No 3. Changes in accounting estimates: Yes (Note) For details, please refer to P.12 '(Changes in Accounting Estimates)' in the 'Condensed Interim Consolidated Financial Statements, (5) Notes to Condensed Interim Consolidated Financial Statements.' 4.3 Number of shares issued and outstanding (common stock) 1. Number of shares issued and outstanding (including treasury stock) As of June 30, 2025: 1,870,614,885 shares As of December 31, 2024: 1,870,614,885 shares 2. Number of treasury stock As of June 30, 2025: 61,430,002 shares As of December 31, 2024: 75,848,895 shares 3. Average number of shares issued and outstanding Six months ended June 30, 2025: 1,801,305,034 shares Six months ended June 30, 2024: 1,783,808,662 shares (Note) Information regarding the implementation of audit procedures: These financial results are not subject to interim review procedures by the independent auditor. Expand Cautionary Statement The Group will hold an earnings conference for institutional investors and analysts on July 25, 2025. The Group plans to post the materials which are provided at the meeting, on the Group's website on that day. The statements with respect to the financial outlook of Renesas Electronics Corporation (hereinafter 'the Company') and its consolidated subsidiaries (hereinafter 'the Group') are forward-looking statements involving risks and uncertainties. We caution you in advance that actual results may differ materially from such forward-looking statements due to changes in several important factors. Expand About Renesas Electronics Corporation Renesas Electronics Corporation (TSE: 6723) empowers a safer, smarter and more sustainable future where technology helps make our lives easier. A leading global provider of microcontrollers, Renesas combines our expertise in embedded processing, analog, power and connectivity to deliver complete semiconductor solutions. These Winning Combinations accelerate time to market for automotive, industrial, infrastructure and IoT applications, enabling billions of connected, intelligent devices that enhance the way people work and live. Learn more at Follow us on LinkedIn, Facebook, Twitter, YouTube, and Instagram. The statements in this press release with respect to the plans, strategies and financial outlook of Renesas and its consolidated subsidiaries (collectively 'we') are forward-looking statements involving risks and uncertainties. Such forward-looking statements do not represent any guarantee by management of future performance. In many cases, but not all, we use such words as 'aim,' 'anticipate,' 'believe,' 'continue,' 'endeavor,' 'estimate,' 'expect,' 'initiative,' 'intend,' 'may,' 'plan,' 'potential,' 'probability,' 'project,' 'risk,' 'seek,' 'should,' 'strive,' 'target,' 'will' and similar expressions to identify forward-looking statements. You can also identify forward-looking statements by discussions of strategy, plans or intentions. These statements discuss future expectations, identify strategies, contain projections of our results of operations or financial condition, or state other forward-looking information based on our current expectations, assumptions, estimates and projections about our business and industry, our future business strategies and the environment in which we will operate in the future. Known and unknown risks, uncertainties and other factors could cause our actual results, performance or achievements to differ materially from those contained or implied in any forward-looking statement, including, but not limited to, general economic conditions in our markets, which are primarily Japan, North America, Asia, and Europe; demand for, and competitive pricing pressure on, products and services in the marketplace; ability to continue to win acceptance of products and services in these highly competitive markets; and fluctuations in currency exchange rates, particularly between the yen and the U.S. dollar. Among other factors, downturn of the world economy; deteriorating financial conditions in world markets, or deterioration in domestic and overseas stock markets, may cause actual results to differ from the projected results forecast. This press release is based on the economic, regulatory, market and other conditions as in effect on the date hereof. It should be understood that subsequent developments may affect the information contained in this presentation, which neither we nor our advisors or representatives are under an obligation to update, revise or affirm.


Business Wire
25 minutes ago
- Business Wire
Asia Pacific Firms Use Google Cloud to Modernize, Innovate
SYDNEY--(BUSINESS WIRE)--Enterprises in Asia Pacific are adopting Google Cloud solutions to remain competitive by modernizing complex IT infrastructure and making better use of data, according to a new research report published today by Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm. Companies in Asia Pacific need to move data and workloads from legacy systems to modern, scalable platforms for future agility. Many are turning to Google and its provider partners for the tools and services they need for that transition. The 2025 ISG Provider Lens ® Google Cloud Partner Ecosystem report for Asia Pacific finds that companies in the region are transforming their digital infrastructures through cloud migration and data innovation. While keeping up with rapidly evolving technologies, enterprises in Asia Pacific are also under growing pressure to control costs, making it imperative that they maximize their return on cloud investments. Google Cloud's focus on addressing these challenges positions it as a preferred partner in the region. 'Companies in Asia Pacific need to move data and workloads from legacy systems to modern, scalable platforms for future agility,' said Michael Gale, partner and regional leader, ISG Asia Pacific. 'Many are turning to Google and its provider partners for the tools and services they need for that transition.' Demand for cloud services is rising quickly in Asia Pacific, accelerated by the need for better flexibility and operational performance, the report says. Companies need effective, reliable cloud solutions to support a growing number of applications, including business intelligence and customer relationship management. Cloud adoption varies widely with differing levels of digital maturity in the region. Established markets such as Australia and New Zealand lead in advanced cloud solutions, while companies in emerging markets are rapidly integrating cloud services. In Southeast Asia, some governments are encouraging the trend with initiatives to promote digital economies. Generative AI is also gaining traction among enterprises in the region as companies begin to see it as essential for improved operational efficiency and customer engagement, ISG says. Enterprises are exploring GenAI applications including chatbots, predictive analytics and workflow automation. Google Cloud's AI and ML tools, such as Vertex AI, are becoming integral to these efforts. The rise of AI in Asia Pacific is also increasing demand for managed services to deploy and run AI solutions. Many enterprises in Asia Pacific are adopting hybrid cloud and multicloud strategies to balance flexibility, scalability and control by combining on-premises and public cloud resources, the report says. They are turning to service providers offering comprehensive support for these strategies, including tools such as Google Anthos for workload management across clouds. The rising importance of advanced analytics and data visualization in the region also is driving adoption of Google Cloud solutions, ISG says. Companies are seeking real-time analytics backed by a focus on data quality and governance. 'Enterprises in Asia Pacific are recognizing that their data needs to be accurate, accessible and compliant with data protection laws,' said Sonam Chawla, lead analyst, ISG Provider Lens Research, and lead author of the report. 'Solutions that support these strategic objectives help to create trust among companies and their partners.' The report also examines other trends in the Asia Pacific Google Cloud ecosystem, including growing demand for AI-enabled supply chain management and the rising need for data localization and security to comply with national laws. For more insights into Google Cloud-related challenges facing enterprises in Asia Pacific, plus ISG's advice for addressing them, see the ISG Provider Lens ® Focal Points briefing here. The 2025 ISG Provider Lens ® Google Cloud Partner Ecosystem report for Asia Pacific evaluates the capabilities of 32 providers across four quadrants: Google Cloud Professional Services (Consulting and Migration), Google Cloud Managed Services, Google Cloud Enterprise Data Infrastructure Services and Google Cloud GenAI and AI Services. The report names Accenture, Capgemini, Cognizant, HCLTech, Infosys, Persistent Systems, TCS and Wipro as Leaders in all four quadrants. It names Tech Mahindra as a Leader in two quadrants and DXC Technology, LTIMindtree, Mantel Group and Quantiphi as Leaders in one quadrant each. In addition, NTT DATA is named as a Rising Stars — a company with a 'promising portfolio' and 'high future potential' by ISG's definition — in two quadrants. Cloud4C and Searce are named as Rising Stars in one quadrant each. In the area of customer experience, Persistent Systems is named the global ISG CX Star Performer for 2025 among Google Cloud Partners Ecosystem providers. Persistent Systems earned the highest customer satisfaction scores in ISG's Voice of the Customer survey, part of the ISG Star of Excellence™ program, the premier quality recognition for the technology and business services industry. The 2025 ISG Provider Lens ® Google Cloud Partner Ecosystem report for Asia Pacific is available to subscribers or for one-time purchase on this webpage. About ISG Provider Lens ® Research The ISG Provider Lens ® Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across Europe, as well as in the U.S., Canada, Mexico, Brazil, the U.K., France, Benelux, Germany, Switzerland, the Nordics, Australia and Singapore/Malaysia, with additional markets to be added in the future. For more information about ISG Provider Lens research, please visit this webpage. About ISG ISG (Nasdaq: III) is a global AI-centered technology research and advisory firm. A trusted partner to more than 900 clients, including 75 of the world's top 100 enterprises, ISG is a long-time leader in technology and business services that is now at the forefront of leveraging AI to help organizations achieve operational excellence and faster growth. The firm, founded in 2006, is known for its proprietary market data, in-depth knowledge of provider ecosystems, and the expertise of its 1,600 professionals worldwide working together to help clients maximize the value of their technology investments.